Doctor's Bio
Dr. Cletus A. Arciero, MD, is a surgical oncologist who specializes in the diagnosis and surgical treatment of breast cancer and other breast conditions. At Grady, he works closely with a multidisciplinary team to provide personalized, compassionate care, helping patients navigate every stage of diagnosis, treatment, and recovery.
Using the latest surgical techniques, Dr. Arciero is committed to delivering high-quality, patient-centered care that emphasizes the best possible outcomes while preserving quality of life. He partners with medical oncologists, radiation oncologists, radiologists, pathologists, and support services to ensure each patient receives a coordinated treatment plan tailored to their individual needs.
In addition to caring for patients, Dr. Arciero is dedicated to advancing breast cancer care through education and clinical research, helping train future surgeons and supporting innovations that improve treatment options for patients.
Board Certifications
American Board of Surgery
Affiliations
Emory
Education & Training
- Medical School: Uniformed Services University of the Health Sciences
- Residency: Walter Reed Army Medical Center
Fellowships
Fox Chase Cancer Center
Locations and Directions
Grady Memorial Hospital
OPEN 24 HOURS
Visiting hours are from 8 a.m. – 10:30 p.m. daily
Publications
- De-Escalating Axillary Surgery in Select Patients With Clinically Palpable Nodal Disease.
King TA, Arciero CA
JAMA surgery. 2026;161(7):668-669.
PMID: 42090161 - Synchronous Bilateral In Situ Solid Papillary Carcinoma of the Breast: A Report of a Rare Case.
Shackelford RE, Fan X, Martin AS, Arciero CA, Wei EX
Cureus. 2025;17(10):e95543.
PMID: 41322935 - Long-term follow-up confirms patients with high-risk breast lesions can be successfully managed at a multidisciplinary conferences.
Yang W, Alongi A, Ma Z, Styblo TM, Arciero CA, Farley C, Ho C, O'Regan RM, Cohen MA, Bagadiya N, Li X
Breast cancer research and treatment. 2025;214(3):409-418.
PMID: 41004069 - Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial.
Van Hassel J, Dimitroff K, Yau C, Mukhtar R, Boughey JC, Ladores V, Howard-McNatt MM, Jaskowiak N, Perlmutter J, DeMichele A, Yee D, Hylton N, Symmans WF, Veer LV, Rugo H, Esserman LJ, Shatsky R, Isaacs C, Kuerer H, Wallace AM, Prionas N, Tseng J, Reyna CR, Taunk N, Kesmodel S, Lee MC, Fox J, Piltin MA, Tchou J, Arciero CA, Postlewait LM, Sauder C, Rao R
Annals of surgical oncology. 2025;32(11):8113-8126.
PMID: 40849380 - Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
Mukhtar RA, Dimitroff K, Yau C, Chien AJ, Connolly EP, Howard-McNatt M, Rao R, Ladores V, Golshan M, Sauder CA, Ahmed K, Lancaster R, Fox J, Gutnik L, Lee MC, Tchou J, Prionas N, Arciero CA, Reyna C, Kuerer H, Switalla K, Taunk N, Tuttle TM, Moran MS, Postlewait LM, Perlmutter J, DeMichele A, Yee D, Hylton N, Symmans WF, Rugo HS, Shatsky R, Isaacs C, Esserman LJ, Van't Veer L, Boughey JC
Annals of surgical oncology. 2025;32(11):8243-8253.
PMID: 40705266 - Postmastectomy Radiation Therapy for Intermediate-Risk Breast Cancer Patients With 0-3 Positive Axillary Lymph Nodes: Emulating the SUPREMO Trial Using Real-World Data.
Kulkarni SE, Patel SA, Jiang C, Schwieger L, Postlewait LM, Arciero CA, Gillespie TW, Liu Y
Clinical breast cancer. 2025;25(5):e655-e665.e4.
PMID: 40187907 - Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.
Boughey JC, Yu H, Switalla K, Velle L, Lopes A, Wallace AM, Lancaster RB, Reyna CR, Tuttle TM, Jaskowiak N, Tchou J, Rao R, Lee MC, Naik AM, Golshan M, Arciero CA, Sauder CAM, Matsen CB, Yau C, Esserman L, Mukhtar RA,
Annals of surgical oncology. 2025;32(5):3278-3291.
PMID: 39946078 - Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA
Annals of surgical oncology. 2024;31(11):7249-7259.
PMID: 38995451 - Patterns of completion axillary dissection for patients with cT1-2N0 breast cancer undergoing total mastectomy with positive sentinel lymph nodes.
Schwieger L, Postlewait LM, Subhedar PD, Geng F, Liu Y, Gillespie T, Arciero CA
Journal of surgical oncology. 2024;129(3):468-480.
PMID: 37955191 - Did Medicaid Expansion Mitigate Disparities in Post-mastectomy Reconstruction Rates?
Goldenberg AR, Willcox LM, Abolghasemi DM, Jiang R, Wei ZZ, Arciero CA, Subhedar PD
The American surgeon. 2022;88(5):846-851.
PMID: 34974716
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.